Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CN201910111577.2Aexternal-prioritypatent/CN109848942A/zh
Application filed by Chia Tai Tianqing Pharmaceutical Group Co LtdfiledCriticalChia Tai Tianqing Pharmaceutical Group Co Ltd
Priority claimed from PCT/CN2020/074220external-prioritypatent/WO2020156577A1/zh
Publication of MX2021009293ApublicationCriticalpatent/MX2021009293A/es
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
Se describe un tipo de compuestos indol heptamil oxima como inhibidor de PARP. Se describen específicamente un compuesto representado por la fórmula (II) y una sal farmacéuticamente aceptable del mismo. (ver Fórmula).
MX2021009293A2019-02-022020-02-03Analogo de indol heptamiloxima como inhibidor de parp.
MX2021009293A
(es)